Profil
Mr. Joshua Golomb is a Partner at OrbiMed Advisors LLC and a Partner at OrbiMed Advisors Private Equity.
He has over 20 yrs of investing experience in both Biotech and Pharmaceuticals.
Prior to joining OrbiMed, Mr. Golomb was an Analyst at HealthCor covering biotechnology and pharmaceuticals.
Previously, he covered the same sectors as a buyside Analyst at Millennium, Citadel, Diamondback and ProMed.
He holds a B.S.
in Operations Research with a concentration in Engineering Management Systems from the Fu Foundation School of Engineering and Applied Science at Columbia University.
Postes actifs de Joshua Golomb
| Sociétés | Poste | Début |
|---|---|---|
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | - |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Analyst-Equity | 01/01/2021 |
Anciens postes connus de Joshua Golomb
| Sociétés | Poste | Fin |
|---|---|---|
PioneerPath Capital
PioneerPath Capital Investment ManagersFinance PioneerPath Capital provides individuals with emerging investment talent in the hedge fund industry with a platform to further develop their investment and non-investment frameworks. The firm seeks to identify investment professionals that provide complementary capabilities to Citadel Alternative Asset Management's current franchise. Their platform is designed to provide trading infrastructure, committed capital, a risk framework and a defined exit strategy, which may include, among other options, seed capital | Analyst-Equity | - |
Diamondback Capital Management LLC
Diamondback Capital Management LLC Investment ManagersFinance Diamondback Capital Management specializes in the systematic trading of US long/short equities. The objective of the firm's Master Fund is to generate above average, positive returns that are not correlated to the primarily US equity markets. The fund may invest or trade (on margin or otherwise) long and short positions in all types of US and non-US securities, derivatives and other financial instruments including, but not limited to: (1) US and non-US common stocks and preferred stocks (2) bonds, notes, commercial paper, bank deposits and acceptances (3) any other obligations and instruments, evidences of indebtedness or securities, rights, warrants and options to purchase or sell any of the foregoing or any securities index (4) total return swaps, interest rate, security and currency swaps, caps, floors, contracts for differences (5) other notional principal contracts, repurchase and reverse repurchase contracts, currency forward contracts and (6) stock and financial futures and options, commodity futures and options on futures. Diamondback Capital management may employ any or all of the following investment strategies: (1) long/short equity investment strategies (2) event-driven strategies including merger arbitrage (3) convertible bond and capital structure arbitrage and other related strategies (4) quantitative trading strategies including statistical arbitrage (5) fixed-income strategies (6) credit and distressed trading strategies (7) global macro strategies (8) commodities strategies and (9) index-based strategies. The firm's long/short equity strategies focus on investing and trading long and/or short positions in equity securities in US and international sectors and sub-sectors including the financial, healthcare, industrial and cyclical, consumer and retail, telecommunication, media and technology, energy and insurance sectors. Their event-driven strategies involve investment opportunities resulting from transactional events such as spin-offs, mergers and acquisitions, bankruptcy reorganizations, recapitalizations and share buybacks, as well as merger arbitrage strategies. Diamondback's convertible bond and capital structure arbitrage generally involves investments in convertible and derivative securities designed to take advantage of price discrepancies between the convertible and derivative security and the underlying equity security or other convertible or derivative security. These investments may be made at multiple levels of an entity's capital structure to take advantage of valuation or other pricing discrepancies. These strategies may also use options to hedge equity exposure and asset swaps and credit default swaps to hedge credit risk. The firm's quantitative trading strategies use historical price data in an effort to anticipate future price movements. These strategies typically rely heavily or entirely on computer-generated trading signals and trading systems to initiate, maintain and liquidate positions. The fund may also employ quantitative methods that seek to allocate capital among the different investment strategies that Diamondback identifies as having the most profit potential, based on the historical performance of the strategies and their judgment. Diamondback's fixed-income strategies primarily focus on taking advantage of relative mispricings between related fixed-income securities through convergence/divergence trades. Certain of these trading strategies arbitrage different maturities on the fixed-income yield curve by taking long positions in higher yielding, longer duration fixed income instruments and short positions in lower yielding, shorter duration instruments; others implement a variety of hedged, spread and outright trading approaches, focusing on both relative and absolute interest-rate movements. The firm's credit and distressed trading efforts focus on investing and trading in bank loans and participations, credit default swaps, collateralized debt obligations, bonds and other credit-related instruments. Certain of these strategies are highly issuer-specific, and may involve issuers experiencing significant financial or business difficulties, while others rely more on probabilistic statistics projecting likely payout streams. Given the volatility in the credit markets over the last few years, there may be substantial risks, as well as opportunities, in these strategies. Diamondback's global macro strategies seek to analyze shifts in macroeconomic trends and to capitalize on directional opportunities across a broad spectrum of markets, asset classes and financial instruments. The firm trades commodities trading opportunistically and employs a wide range of volatility, directional, relative value, hybrid and other strategies. The fund may invest in:(1) energy products including heating oil, light crude oil, natural gas and unleaded gasoline (2) precious metals including platinum, silver, gold and palladium (3) base metals including copper, zinc, tin and lead (4) agriculturals (including wheat, soybeans, soybean oil, live hogs, hog bellies, live cattle and corn); and the so-called softs such as cocoa, coffee, cotton and sugar. Diamondback's index-based strategies may involve trading publicly-traded equity securities, equity indices and ETFs with the objective of tracking additions, deletions, upweights, downweights and rebalancings in G20 and other major market indices. In general, Diamondback tends to invest in the stocks of companies in the finance, industrial services, energy minerals, healthcare technology and technology services sectors. The firm invests globally, across all market caps. Diamondback maintains a high turnover rate. | Analyst-Equity | 31/08/2010 |
ProMed Management, Inc.
ProMed Management, Inc. Investment ManagersFinance ProMed Management invests mainly in healthcare stocks with a value bias. The firm's investment focus includes biotechnology, pharmaceuticals and medical devices | Analyst-Equity | - |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Analyst-Equity | - |
Critical Mass Partners LLC
Critical Mass Partners LLC Investment ManagersFinance Critical Mass Partners manages a long/short equity hedge fund that focuses on investments in the healthcare, industrial and consumer sectors. | Analyst-Equity | - |
Formation de Joshua Golomb
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
ProMed Management, Inc.
ProMed Management, Inc. Investment ManagersFinance ProMed Management invests mainly in healthcare stocks with a value bias. The firm's investment focus includes biotechnology, pharmaceuticals and medical devices | Finance |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Diamondback Capital Management LLC
Diamondback Capital Management LLC Investment ManagersFinance Diamondback Capital Management specializes in the systematic trading of US long/short equities. The objective of the firm's Master Fund is to generate above average, positive returns that are not correlated to the primarily US equity markets. The fund may invest or trade (on margin or otherwise) long and short positions in all types of US and non-US securities, derivatives and other financial instruments including, but not limited to: (1) US and non-US common stocks and preferred stocks (2) bonds, notes, commercial paper, bank deposits and acceptances (3) any other obligations and instruments, evidences of indebtedness or securities, rights, warrants and options to purchase or sell any of the foregoing or any securities index (4) total return swaps, interest rate, security and currency swaps, caps, floors, contracts for differences (5) other notional principal contracts, repurchase and reverse repurchase contracts, currency forward contracts and (6) stock and financial futures and options, commodity futures and options on futures. Diamondback Capital management may employ any or all of the following investment strategies: (1) long/short equity investment strategies (2) event-driven strategies including merger arbitrage (3) convertible bond and capital structure arbitrage and other related strategies (4) quantitative trading strategies including statistical arbitrage (5) fixed-income strategies (6) credit and distressed trading strategies (7) global macro strategies (8) commodities strategies and (9) index-based strategies. The firm's long/short equity strategies focus on investing and trading long and/or short positions in equity securities in US and international sectors and sub-sectors including the financial, healthcare, industrial and cyclical, consumer and retail, telecommunication, media and technology, energy and insurance sectors. Their event-driven strategies involve investment opportunities resulting from transactional events such as spin-offs, mergers and acquisitions, bankruptcy reorganizations, recapitalizations and share buybacks, as well as merger arbitrage strategies. Diamondback's convertible bond and capital structure arbitrage generally involves investments in convertible and derivative securities designed to take advantage of price discrepancies between the convertible and derivative security and the underlying equity security or other convertible or derivative security. These investments may be made at multiple levels of an entity's capital structure to take advantage of valuation or other pricing discrepancies. These strategies may also use options to hedge equity exposure and asset swaps and credit default swaps to hedge credit risk. The firm's quantitative trading strategies use historical price data in an effort to anticipate future price movements. These strategies typically rely heavily or entirely on computer-generated trading signals and trading systems to initiate, maintain and liquidate positions. The fund may also employ quantitative methods that seek to allocate capital among the different investment strategies that Diamondback identifies as having the most profit potential, based on the historical performance of the strategies and their judgment. Diamondback's fixed-income strategies primarily focus on taking advantage of relative mispricings between related fixed-income securities through convergence/divergence trades. Certain of these trading strategies arbitrage different maturities on the fixed-income yield curve by taking long positions in higher yielding, longer duration fixed income instruments and short positions in lower yielding, shorter duration instruments; others implement a variety of hedged, spread and outright trading approaches, focusing on both relative and absolute interest-rate movements. The firm's credit and distressed trading efforts focus on investing and trading in bank loans and participations, credit default swaps, collateralized debt obligations, bonds and other credit-related instruments. Certain of these strategies are highly issuer-specific, and may involve issuers experiencing significant financial or business difficulties, while others rely more on probabilistic statistics projecting likely payout streams. Given the volatility in the credit markets over the last few years, there may be substantial risks, as well as opportunities, in these strategies. Diamondback's global macro strategies seek to analyze shifts in macroeconomic trends and to capitalize on directional opportunities across a broad spectrum of markets, asset classes and financial instruments. The firm trades commodities trading opportunistically and employs a wide range of volatility, directional, relative value, hybrid and other strategies. The fund may invest in:(1) energy products including heating oil, light crude oil, natural gas and unleaded gasoline (2) precious metals including platinum, silver, gold and palladium (3) base metals including copper, zinc, tin and lead (4) agriculturals (including wheat, soybeans, soybean oil, live hogs, hog bellies, live cattle and corn); and the so-called softs such as cocoa, coffee, cotton and sugar. Diamondback's index-based strategies may involve trading publicly-traded equity securities, equity indices and ETFs with the objective of tracking additions, deletions, upweights, downweights and rebalancings in G20 and other major market indices. In general, Diamondback tends to invest in the stocks of companies in the finance, industrial services, energy minerals, healthcare technology and technology services sectors. The firm invests globally, across all market caps. Diamondback maintains a high turnover rate. | Finance |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
PioneerPath Capital
PioneerPath Capital Investment ManagersFinance PioneerPath Capital provides individuals with emerging investment talent in the hedge fund industry with a platform to further develop their investment and non-investment frameworks. The firm seeks to identify investment professionals that provide complementary capabilities to Citadel Alternative Asset Management's current franchise. Their platform is designed to provide trading infrastructure, committed capital, a risk framework and a defined exit strategy, which may include, among other options, seed capital | Finance |
Critical Mass Partners LLC
Critical Mass Partners LLC Investment ManagersFinance Critical Mass Partners manages a long/short equity hedge fund that focuses on investments in the healthcare, industrial and consumer sectors. | Finance |
















